Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

French team disqualified from the Olympics
eventing
Following the French team's disqualification, Canada now qualifies for Rio 2016 (generic image)
Horse tests positive for banned sedative

A French eventing team has lost its spot in the 2016 Olympic Games in Rio after one of its horses tested positive for a controlled medication substance.

Samples taken from the horse, Qalao des Mers, in August last year found Hydroxyethylpromazine sulfoxide. The substance is a metabolite of the sedative, Acepromazine, which is on the FEI prohibited substances list.

Controlled medications are defined as those that are commonly used to treat horses, but are prohibited in competitions to maintain fairness.

The horse and its rider, Maxime Livio, were disqualified along with their team from the eventing competition at the FEI World Equestrian Games 2014.

The FEI Tribunal will make a final decision on further sanctions at a later date.

Livio came fifth in the individual rankings and the team finished fourth in Normandy, securing their slot in the Olympic Games.

Following the French team's disqualification, the Canadian eventing team has moved up to sixth place and qualifies for Rio 2016. Other nations so far competing in next year's games are Great Britain, Ireland, Germany, Australia, the Netherlands and Brazil as the host country.

Another case against Livio was dropped earlier this month. A borrowed horse ridden by Livio at a jumping event in Thailand last November initially tested positive but a second sample failed to confirm this.



Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'